Skye Bioscience, Inc. Loans Payable, Current
Skye Bioscience, Inc. (SKYE) had Loans Payable, Current of $143.05 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Long-Term Debt, Current Maturities
us-gaap:LoansPayableCurrent · last filed 2026-08-14
- 2026-06-30: Loans Payable, Current $143.05K.
- 2026-03-31: Loans Payable, Current $250.34K.
- 2026-02-01: Loans Payable, Current $321.86K.
- 2025-12-31: Loans Payable, Current $0.00.
| Period end | Loans Payable, Current | Loans Payable, Current as first filed |
|---|---|---|
| 2026-06-30 | $143.05K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $250.34K 10-Q · filed 2026-05-11 | |
| 2026-02-01 | $321.86K 10-Q · filed 2026-08-14 | |
| 2025-12-31 | $0.00 10-Q · filed 2026-08-14 | |
| 2023-09-30 | $22.65K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $90.61K 10-Q · filed 2023-08-07 | |
| 2023-03-31 | $158.58K 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $55.45K 10-Q · filed 2023-11-14 | $0.00 10-Q · filed 2023-05-12 |
| 2022-09-30 | $30.61K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $122.46K 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $214.31K 10-Q · filed 2022-05-06 | |
| 2021-12-31 | $0.00 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |